An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes-Reference-Cited by-同舟云学术

An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes

Published:2019-07 Issue: Volume:30 Page:iv126
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Reni M.,Riess H.,O’Reilly E.,Santoro A.,Park J.,Bekaii-Saab T.,Tempero M.,Shan Y.,Macarulla T.,Van Cutsem E.,Noel M.,Berlin J.,Biankin A.,Dhani N.,Frassineti G.,Goldstein D.,Romano A.,Bruchec Y. Le,Philip P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/30/Supplement_4/mdz154/28915589/mdz154.pdf

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Primary Pancreatic Cancer;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23

2. Neoadjuvant chemotherapy associated with isotoxic high‐dose stereotactic body radiotherapy does not increase postoperative complications after pancreaticoduodenectomy for nonmetastatic pancreatic cancer;Journal of Surgical Oncology;2023-03-31

3. Aktuelle Systemtherapie für fortgeschrittene biliäre Tumoren;Der Onkologe;2022-03-15

4. What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?;Annals of Surgical Oncology;2021-01-21

5. Elucidating the Causes of Improved Survival in Clinical Trials of Randomized Adjuvant Pancreatic Ductal Adenocarcinoma (PDAC);Annals of Surgical Oncology;2020-09-23